{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:46:34Z","timestamp":1793202394911,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-RW320-008"],"award-info":[{"award-number":["2021-RW320-008"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018543","name":"Natural Science Foundation of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["XZ2022ZR-ZY03"],"award-info":[{"award-number":["XZ2022ZR-ZY03"]}],"id":[{"id":"10.13039\/501100018543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.amjmed.2025.05.038","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T18:53:13Z","timestamp":1749235993000},"page":"1408-1417.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Dual Antiplatelet Therapy Duration on Long-Term Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-9623","authenticated-orcid":false,"given":"Yao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjmed.2025.05.038_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.120.046754","article-title":"definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations","volume":"143","author":"Ybarra","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.038_bib0002","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jcin.2014.12.238","article-title":"Safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: results from the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions)","volume":"8","author":"Kandzari","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"26","key":"10.1016\/j.amjmed.2025.05.038_bib0003","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.038_bib0004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1536\/ihj.20-427","article-title":"Randomized controlled comparison of optimal medical therapy with percutaneous recanalization of chronic total occlusion (COMET-CTO)","volume":"62","author":"Juricic","year":"2021","journal-title":"Int Heart J"},{"issue":"13","key":"10.1016\/j.amjmed.2025.05.038_bib0005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jcin.2018.04.017","article-title":"The IMPACTOR-CTO Trial","volume":"11","author":"Obedinskiy","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"36","key":"10.1016\/j.amjmed.2025.05.038_bib0006","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Christiaan","year":"2024","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.amjmed.2025.05.038_bib0007","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.amjmed.2025.05.038_bib0008","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2015.03.541","article-title":"Double antiplatelet therapy duration: standardize or personalize?","volume":"65","author":"Gilard","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.amjmed.2025.05.038_bib0009","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","article-title":"Efficacy and safety of dual antiplatelet therapy after complex PCI","volume":"68","author":"Giustino","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.amjmed.2025.05.038_bib0010","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.amjmed.2025.05.038_bib0011","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcin.2020.10.003","article-title":"Association of acute procedural results with long-term outcomes after CTO PCI","volume":"14","author":"Guan","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2025.05.038_bib0012","first-page":"996","article-title":"Association of symptom status, myocardial viability, and clinical\/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention","volume":"97","author":"Song","year":"2021","journal-title":"Catheter Cardio Intervent"},{"issue":"3","key":"10.1016\/j.amjmed.2025.05.038_bib0013","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.038_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008530","article-title":"Clinical usefulness of PRECISE-DAPT score for predicting bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an analysis from the SMART-DATE randomized trial","volume":"13","author":"Choi","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.038_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011536","article-title":"New insights into long- versus short-term dual antiplatelet therapy duration in patients after stenting for left main coronary artery disease: findings from a prospective observational study","volume":"15","author":"Wang","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.038_bib0016","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jacc.2013.09.043","article-title":"Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia)","volume":"63","author":"Campo","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.amjmed.2025.05.038_bib0017","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jcin.2017.04.019","article-title":"Dual antiplatelet therapy for 6 versus 18 months after biodegradable polymer drug-eluting stent implantation","volume":"10","author":"Nakamura","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.amjmed.2025.05.038_bib0018","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2018.11.048","article-title":"Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting","volume":"73","author":"Costa","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.038_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176737","article-title":"Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2025.05.038_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2020.06.066","article-title":"Duration of dual antiplatelet therapy after percutaneous coronary intervention for chronic total occlusion","volume":"132","author":"Sachdeva","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2025.05.038_bib0021","article-title":"Treatment outcomes of clopidogrel in patients with ACS and diabetes undergoing PCI\u2013analysis of Beijing municipal medical insurance database","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.amjmed.2025.05.038_bib0022","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/09537104.2019.1693036","article-title":"Long-term outcomes of extending dual antiplatelet therapy after drug-eluting stent implantation for acute coronary syndrome: a large single-center study","volume":"31","author":"Xu","year":"2020","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.amjmed.2025.05.038_bib0023","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CM9.0000000000001289","article-title":"Long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion","volume":"134","author":"Gong","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.amjmed.2025.05.038_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.04.012","article-title":"Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease","volume":"328","author":"Zheng","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjmed.2025.05.038_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.carrev.2021.06.129","article-title":"Long-term vascular function in CTO recanalization: a randomized clinical trial of ticagrelor vs. clopidogrel","volume":"37","author":"Rodriguez-Arias","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"issue":"18","key":"10.1016\/j.amjmed.2025.05.038_bib0026","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.amjmed.2025.05.038_bib0027","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934325003481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934325003481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:58:18Z","timestamp":1777399098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934325003481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002934325003481"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.05.038","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Dual Antiplatelet Therapy Duration on Long-Term Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}